All lobbying filings
Ballard Spahr LLP
Ballard Spahr LLP filed a Q3 report for Cencora, Inc. on October 20, 2026, reporting $50,000 in lobbying income.
Lobbying for Cencora, Inc. · ​Pharmaceutical sourcing and distribution services company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Pennsylvania
Government bodies contacted
2
Lobbying activity
2
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Extend payment increase under Medicare's physician fee schedule. Reimbursement policies impacting drug shortages Preventing and Mitigating Generic Drug Shortages
Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)